Mary Jane Pionk
Developmental - Behavioral Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Mary Jane Pionk’s office at (408) 358-2755 to ask if they take your plan before you enroll.
California Medical Board record
Licence G78133 · Current
Licensed to practise in California · since 1993 · expires 2027-06-30 · Michigan State University College of Human Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,243 in 2024
Medicaid paid $1,243 for 63 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 37 | $1,101 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 26 | $142 |
| 2024 | 63 | 2 | 14 | $1,243 |
| 2023 | 40 | 2 | 14 | $707 |
See the largest Medicaid services in earlier years
2023
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 28 | $358 |
| Long return visit (40+ min) | 12 | $349 |
Money from drug and device companies
$531 in 2025
| 2025 | 6 | 13 | None | $531 |
| 2024 | 3 | 5 | None | $260 |
| 2023 | 2 | 4 | None | $89 |
| 2022 | 3 | 34 | None | $462 |
| 2021 | 4 | 31 | None | $493 |
| 2020 | 3 | 9 | None | $170 |
| 2019 | 3 | 28 | None | $412 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Supernus Pharmaceuticals | Qelbree | $240 | 5 payments
|
| BioMarin Pharmaceutical | None | $121 | 1 payment
|
| Collegium Pharmaceutical | Jornay Pm | $87 | 4 payments
|
| Astellas Pharma US | None | $37 | 1 payment
|
| Neos Therapeutics LP | Cotempla Xr-Odt | $24 | 1 payment
|
| Noven Therapeutics | Xelstrym | $22 | 1 payment
|
See all 13 published payments
| Supernus Pharmaceuticals | Meals · 2025-10-16 | Qelbree | $28 |
| Astellas Pharma US | Meals · 2025-10-10 | None | $37 |
| BioMarin Pharmaceutical | Meals · 2025-10-09 | None | $121 |
| Noven Therapeutics | Meals · 2025-10-01 | Xelstrym | $22 |
| Supernus Pharmaceuticals | Meals · 2025-09-25 | Qelbree | $125 |
| Collegium Pharmaceutical | Meals · 2025-09-05 | Jornay Pm | $20 |
| Supernus Pharmaceuticals | Meals · 2025-08-21 | Qelbree | $19 |
| Collegium Pharmaceutical | Meals · 2025-07-10 | Jornay Pm | $27 |
| Supernus Pharmaceuticals | Meals · 2025-06-19 | Qelbree | $27 |
| Neos Therapeutics LP | Meals · 2025-05-29 | Cotempla Xr-Odt | $24 |
| Collegium Pharmaceutical | Meals · 2025-05-01 | Jornay Pm | $20 |
| Collegium Pharmaceutical | Meals · 2025-04-17 | Jornay Pm | $20 |
| Supernus Pharmaceuticals | Meals · 2025-02-06 | Qelbree | $40 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $260
| BioMarin Pharmaceutical | Brineura | $154 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $74 | 2 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $32 | 2 payments
|
2023: $89
| Supernus Pharmaceuticals | Qelbree | $65 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $23 | 1 payment
|
2022: $462
| Supernus Pharmaceuticals | Qelbree | $198 | 16 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $138 | 11 payments
|
| Tris Pharma | Quillivant | $126 | 7 payments
|
2021: $493
| Supernus Pharmaceuticals | Qelbree | $245 | 11 payments
|
| Tris Pharma | Dyanavel Xr | $210 | 18 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $16 | 1 payment
|
2020: $170
| Tris Pharma | Dyanavel Xr | $72 | 4 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $60 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $38 | 2 payments
|
2019: $412
| Tris Pharma | Quillivant Xr | $241 | 19 payments
|
| Vertical Pharmaceuticals | Relexxii | $147 | 8 payments
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $24 | 1 payment
|
Professional record
- NPI
- 1689755167
- Licence
- CA G78133California G78133: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0006X (2080P0006X); Pediatrics (208000000X)
- Mailing address
- 2350 W.El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-18
- NPI last updated
- 2016-02-29
This is when the NPI record was last certified, not a medical board exam.